Analogously, but on the other side of the spectrum, anticoagulant FVIII inhibitors may arise in autoimmune diseases, during and after pregnancy, and during drug therapy including IFN-alpha (used to treat leukemia and blood disorders such as TTP) with the outcome of acquired severe hemophilia. The gene discussed is F8; the disease is thrombotic thrombocytopenic purpura.